Ligustrazine Phosphate and Sodium Chloride Injection

This product has the effects of anti-platelet aggregation, dilation of arterioles, and improvement of microcirculation. Animal experiment results show that this product is non-irritating, non-allergic, and non-hemolytic.

Ligustrazine phosphate

This product is a colorless or almost colorless clear liquid.

Used for ischemic cerebrovascular diseases, such as cerebral ischemia, cerebral thrombosis, and cerebral infarction.

Intravenous drip. 50-100 mg once a day, slowly drip, preferably within 3-4 hours. 10-15 days as a course of treatment, or follow the doctor's advice.

Occasionally, stomach discomfort, dry mouth, and drowsiness may occur; reducing the dosage may alleviate occasional allergic reactions.

1. Patients with a history of allergy to any ingredient in this product are prohibited from using this product. 2. Patients with cerebral hemorrhage or bleeding tendency are prohibited from using this product.

This product is highly acidic and is not suitable for use with alkaline drugs.

Keep away from light and store in a sealed container.

100ml: 0.1g ligustrazine phosphate and 0.9g sodium chloride

Henan Tianfang Huazhong Pharmaceutical Co., Ltd.

• Founded in:

  2002-12-17

• Address:

  No. 024, Beihuan Road, Qingfeng County

• Tax NO.:

  91410922745751554H

• Registered Funds:

  30 million yuan

• Website:

  Log in to view

• Email:

  Log in to view